Try Calculator
← Back to Compound Library HEALING / RECOVERY

KLOW Blend

The KLOW Blend is the most comprehensive healing peptide combination available, combining four powerful research compounds into a single vial: TB-500 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg). This 80 mg total blend represents an advanced approach to tissue repair, inflammation control, and regeneration by adding KPV—a potent anti- inflammatory peptide—to the GLOW Blend formula. Each component serves a distinct purpose within the formulation:

amino-acid protein that promotes cell migration, angiogenesis, and systemic tissue repair through actin regulation.

gastric juice that promotes localized healing, growth factor signaling, and tissue protection through multiple complementary pathways.

stimulating hormone (α-MSH) that provides potent anti-inflammatory effects, gut healing, and immune modulation without affecting pigmentation or hormone levels.

supports collagen synthesis, gene expression modulation, and skin regeneration through copper-dependent enzymatic pathways. The “K” in KLOW refers to KPV, the additional peptide that distinguishes this blend from the GLOW Blend. While GLOW provides healing plus anti-aging support, KLOW adds serious anti- inflammatory and gut-healing capability. The KLOW Blend functions as a complete package: injury recovery, systemic healing, inflammation control, gut support, and anti-aging benefits in one vial. This product contains 80 mg of total peptide content. None of these peptides are FDA-approved for human use. BPC-157 and TB-500 are prohibited by the World Anti-Doping Agency (WADA) under the S0 Unapproved Substances category.

Quick Reference

Property TB-500 BPC-157 KPV GHK-Cu Amount per 10 mg 10 mg 10 mg 50 mg

Vial

Amino Acids 43 (protein 15 3 (tripeptide) 3 (tripeptide) fragment) (pentadecapeptide) Molecular 4,963 Da 1,419.5 Da 342.4 Da 403.9 Da

Weight

Primary Actin Growth factor NF-κB Copper Mechanism regulation, cell signaling, inhibition, delivery, gene migration cytoprotection immune expression modulation Primary Systemic Localized healing, Anti- Collagen Benefits healing, gut protection, inflammatory, synthesis, anti- angiogenesis, tissue repair gut barrier, mast aging, skin wound repair cell stabilization quality Distribution Systemic (low Primarily Systemic and Local and MW) localized gut-targeted systemic FDA Status Not approved Not approved Not specifically Not approved (Category 2) (Category 2) regulated (cosmetic use permitted)

How It Works

The KLOW Blend operates through four distinct but complementary mechanisms, creating the most comprehensive approach to healing and inflammation control available in a single formulation.

TB-500 Mechanisms: Systemic Repair Through Actin Regulation

TB-500 (Thymosin Beta-4 Fragment) works systemically through its interaction with monomeric actin (G-actin), the primary building block of the cellular cytoskeleton. TB-500 binds to and sequesters actin monomers, maintaining a reserve pool available for rapid cell mobilization when tissue damage is detected. Its relatively low molecular weight (4,963 Da) allows it to travel efficiently through blood and tissues, promoting cell migration over long distances. TB-500 stimulates angiogenesis (new blood vessel formation), which is essential for delivering nutrients and oxygen to damaged tissues. During metabolism, TB-500 releases the anti- inflammatory tetrapeptide fragment Ac-SDKP, which contributes to inflammation management and fibrosis reduction. Importantly, TB-500 works throughout the body regardless of injection site, providing systemic regenerative support.

BPC-157 Mechanisms: Localized Healing and Tissue Protection

BPC-157 (Body Protection Compound-157) functions as an initiator and protector of the healing response. Its mechanisms include upregulation of vascular endothelial growth factor (VEGF) to promote blood vessel formation, modulation of nitric oxide (NO) synthesis for improved blood flow, and activation of the FAK-paxillin signaling pathway for cell migration and attachment. BPC-157 also increases growth hormone receptor expression in damaged tissues, amplifying the body’s regenerative signaling. A distinguishing feature of BPC-157 is its gastroprotective properties. Derived from a protein found in human gastric juice, BPC-157 supports stomach lining integrity, protects against NSAID-induced gut damage, and provides therapeutic benefit for inflammatory bowel conditions. When injected subcutaneously, BPC-157 tends to concentrate its effects near the injection site, making it particularly effective for targeted injury recovery.

KPV Mechanisms: Anti-Inflammatory and Immune Modulation

KPV (Lys-Pro-Val) is a tripeptide derived from the C-terminal sequence of alpha-melanocyte- stimulating hormone (α-MSH). Research by Luger and Brzoska (2007) demonstrated that most of the anti-inflammatory activities of α-MSH can be attributed to this short C-terminal tripeptide. KPV provides potent anti-inflammatory effects through multiple pathways:

master regulator of inflammatory gene transcription. This blocks the upstream signaling cascade that drives chronic inflammation.

including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6), reducing systemic inflammatory burden.

and MC3R) expressed on immune cells, modulating immune responses without affecting pigmentation.

the PepT1 transporter, allowing it to exert direct anti-inflammatory effects within gut tissue.

junction proteins and reducing intestinal permeability.

symptoms, providing relief from allergic and inflammatory responses.

including Staphylococcus aureus and Candida albicans, adding an additional layer of protection during healing. Importantly, KPV retains the anti-inflammatory benefits of its parent hormone (α-MSH) without affecting pigmentation or hormone levels. Unlike corticosteroids or NSAIDs, KPV does not suppress the immune system or cause the adverse effects associated with conventional anti- inflammatory medications.

GHK-Cu Mechanisms: Gene Expression Modulation and Copper Delivery GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) works through delivery of bioavailable copper to tissues for enzyme activation and broad modulation of gene expression. Research by Pickart and Margolina (2018) demonstrated that GHK-Cu modulates the expression of over 4,000 human genes, generally shifting patterns toward healthier, more youthful states. Copper delivered by GHK-Cu serves as an essential cofactor for lysyl oxidase, an enzyme critical for collagen and elastin cross-linking. GHK-Cu stimulates fibroblast production of collagen, elastin, and glycosaminoglycans while regulating metalloproteinases for balanced collagen turnover. This dual action promotes high-quality tissue repair rather than disordered scar formation. GHK-Cu also provides significant antioxidant and anti-inflammatory effects through upregulation of cellular defense pathways.

Synergy in the KLOW Blend

The four peptides create a complete healing ecosystem by addressing different phases and aspects of tissue repair:

tissues from further damage, and activates repair pathways.

actin-mediated migration while providing systemic anti-inflammatory support via Ac- SDKP release.

tissue damage, allowing the repair peptides to rebuild more effectively. Acts as the “fire extinguisher” that creates an optimal environment for healing.

quality tissue reconstruction, ensuring rebuilt tissue has proper collagen structure and organization.

Benefits

Comprehensive Tissue Healing

The TB-500 and BPC-157 components provide the core healing benefits:

Powerful Anti-Inflammatory Support

The KPV component adds potent inflammation control:

Gut Health and Barrier Support

KPV combined with BPC-157 provides exceptional gut support, making the KLOW Blend the most comprehensive option for gastrointestinal concerns:

Skin and Collagen Support

The GHK-Cu component provides dermatological benefits:

Anti-Aging Benefits

GHK-Cu provides gene expression modulation that supports whole-body anti-aging:

Reduced Injection Site Reactions

The KLOW Blend offers improved tolerability compared to standalone GHK-Cu. Both BPC-157 and KPV help moderate injection site reactions: BPC-157 provides general tissue-protective effects, while KPV stabilizes mast cells and reduces histamine responses. Users often find the KLOW Blend more tolerable than standalone GHK-Cu injections.

What the Science Shows

Research on the individual components of the KLOW Blend is substantial. No studies have examined this specific four-peptide combination, but research on each component supports the rationale for combining them.

KPV Research

Study 1: Dalmasso et al. – Gastroenterology (2008) Design: In vivo study investigating KPV’s mechanism of intestinal uptake and its effects on experimental colitis. Researchers used DSS-induced and TNBS-induced colitis models in mice and evaluated oral administration of KPV. The study also examined KPV’s cellular uptake mechanism using intestinal epithelial cell cultures. Results: KPV was transported into intestinal epithelial cells via the PepT1 transporter. Oral administration of KPV significantly reduced intestinal inflammation in both DSS-induced and TNBS-induced colitis models. KPV treatment decreased pro-inflammatory cytokine expression and improved markers of intestinal barrier integrity. Significance: Identified the specific cellular uptake mechanism (PepT1 transporter) for KPV in the gut and demonstrated that oral KPV is effective against experimental colitis, establishing the scientific basis for KPV’s use in gut inflammation and IBD research. Study 2: Kannengiesser et al. – Inflammatory Bowel Diseases (2008) Design: Preclinical study evaluating KPV’s anti-inflammatory effects in two murine models of colitis: DSS-induced colitis and CD45RBʰⁱ T-cell transfer colitis (a model of chronic, immune- mediated intestinal inflammation). Results: KPV demonstrated significant anti-inflammatory effects in both colitis models. Treatment reduced disease activity indices, decreased inflammatory cell infiltration, and improved histological scores in the affected intestinal tissue. Significance: Confirmed KPV’s anti-inflammatory efficacy across two mechanistically distinct colitis models (chemical-induced and immune-mediated), supporting its potential as a therapeutic option for various forms of inflammatory bowel disease. Study 3: Luger and Brzoska – Annals of the Rheumatic Diseases (2007) Design: Comprehensive review of α-MSH-related peptides and their anti-inflammatory and immunomodulating properties, with specific analysis of the C-terminal tripeptide KPV. Results: The review concluded that most of the anti-inflammatory activities of α-MSH can be attributed to its C-terminal tripeptide KPV. KPV inhibits NF-κB activation and reduces pro- inflammatory cytokine production through melanocortin receptor signaling on immune cells. KPV also demonstrates antimicrobial activity against pathogens including Staphylococcus aureus and Candida albicans.

Significance: Established KPV as the pharmacologically active fragment responsible for α- MSH’s anti-inflammatory effects and identified it as a new class of anti-inflammatory and immunomodulating agent distinct from conventional therapies.

BPC-157 Research

Study 4: Gwyer et al. – Cell and Tissue Research (2019) Design: Systematic review of BPC-157’s effects on musculoskeletal soft tissue healing, analyzing available preclinical data across multiple tissue types including tendons, ligaments, muscles, and bones. Results: BPC-157 demonstrated consistent promotion of healing across musculoskeletal soft tissues with few reported adverse reactions. The compound showed particular promise for healing hypovascular tissues that traditionally present significant clinical challenges. Significance: Established BPC-157 as a promising candidate for soft tissue repair with a favorable safety profile.

TB-500 Research

Study 5: Malinda et al. – Journal of Investigative Dermatology (1999) Design: Preclinical wound healing study evaluating the effects of topical thymosin beta-4 on full-thickness dermal wounds in a rat model, measuring re-epithelialization, wound contraction, and collagen deposition. Results: Thymosin beta-4 increased re-epithelialization by 42% at day 4 and up to 61% at day 7 compared to controls. Wound contraction and collagen deposition were also enhanced. Significance: Provided early quantitative evidence for thymosin beta-4’s wound-healing properties, demonstrating clinically meaningful improvements in tissue repair rates.

GHK-Cu Research

Study 6: Pickart and Margolina – International Journal of Molecular Sciences (2018) Design: Comprehensive review of GHK-Cu’s effects on gene expression using the Broad Institute Connectivity Map (cMap) database. Results: GHK-Cu modulates the expression of over 4,000 human genes, generally shifting patterns toward healthier states. Affected pathways included antioxidant defense, anti- inflammatory response, DNA repair, and tissue remodeling. Significance: Established GHK-Cu as one of the most broadly acting regenerative peptides identified to date.

Dosing Protocol

Important: None of the peptides in the KLOW Blend are FDA-approved for human use. The following dosing information is based on commonly referenced research protocols and community experience. Any use should be under the supervision of a qualified healthcare provider.

Standard Protocol

Parameter Recommendation Notes Frequency Daily or every other Subcutaneous injection day Cycle Length 4 to 8 weeks For injury recovery and tissue repair focus (Healing) Cycle Length 8 to 16 weeks For anti-aging, gut healing, and long-term (Comprehensive) inflammation control Break Between 4 to 6 weeks Allows receptor sensitivity to reset

Cycles

Dose Calculation

The KLOW Blend vial contains 80 mg total (TB-500 10 mg + BPC-157 10 mg + KPV 10 mg + GHK-Cu 50 mg). Reconstituted with 2 mL of bacteriostatic water, the resulting concentration is 40 mg/mL total. Per mL concentration breakdown:

Draw Volume Reference

Volume Units BPC-157 TB-500 KPV GHK-Cu 0.05 mL 5 units 250 mcg 250 mcg 250 mcg 1.25 mg 0.10 mL 10 units 500 mcg 500 mcg 500 mcg 2.5 mg

At 10 units (0.10 mL) daily, one vial lasts approximately 20 days. At 5 units (0.05 mL) daily, one vial lasts approximately 40 days.

Dosing by Application

Gut Inflammation and IBD Support:

Comprehensive Healing (Injury Plus Inflammation):

Anti-Aging Plus Healing Maintenance:

Post-Surgical With Inflammation Control:

Reconstitution Instructions

Materials Needed:

Step-by-Step Instructions:

directly onto the powder or shake vigorously.

content. This is normal and indicates the copper is properly bound to the GHK peptide.

Administration

The KLOW Blend can be injected subcutaneously anywhere due to TB-500’s systemic distribution properties. Common injection sites include the abdomen (lower belly fat), thigh, and upper arm. If you have a specific injury, injecting near that area may maximize BPC-157’s localized effects while still receiving systemic benefits from TB-500, KPV, and GHK-Cu.

Side Effects

The KLOW Blend combines four peptides with generally favorable safety profiles. Side effects are typically mild.

Common Side Effects

Side Effect Frequency Notes Injection site reactions Common Primarily from GHK-Cu; (redness, swelling, itching) moderated by BPC-157 and KPV mast cell stabilization Mild fatigue or lethargy Occasional Usually transient; may occur in first few days Nausea Uncommon Typically mild and self- limiting Headache Uncommon Usually mild; adequate hydration may help

KPV-Specific Safety Profile

KPV is well tolerated with no notable side effects reported in research. Unlike many anti- inflammatory drugs, it does not weaken the immune system or cause the adverse effects associated with corticosteroids or NSAIDs. KPV does not affect pigmentation despite being derived from α-MSH.

GHK-Cu-Specific Considerations

The GHK-Cu component can cause histamine responses at injection sites. However, in the KLOW Blend, both BPC-157 and KPV help moderate these reactions—BPC-157 through general tissue-protective effects and KPV through mast cell stabilization and histamine reduction. Strategies to further minimize injection site reactions include rotating injection sites, allowing the solution to warm to room temperature before injecting, injecting slowly, and applying light pressure after injection.

Theoretical Concerns

BPC-157, TB-500, and GHK-Cu all promote angiogenesis through different pathways. This raises theoretical concerns about use in individuals with existing cancers or tumors, as new blood vessel formation could potentially support tumor growth. No evidence has directly demonstrated this risk in the context of peptide use, but caution is warranted.

Contraindications and Precautions

Do Not Use If You Have:

growth. Three of the four peptides in the blend support blood vessel formation.

MSH derivatives, or copper.

component delivers bioavailable copper and could worsen this condition. Use with Caution:

pregnancy or lactation.

cardiac conditions.

inflammation, the immune-modulating effects of all four peptides warrant caution and medical supervision.

inflammatory agents. Potential interactions with immune-modulating drugs should be discussed with a healthcare provider.

compromised organ function.

KLOW Blend vs. Other Peptide Options

KLOW vs. GLOW Blend

Choose KLOW If: Choose GLOW If: You have significant gut inflammation, IBD, Your primary focus is injury healing plus or leaky gut concerns anti-aging

You need serious anti-inflammatory support You do not have significant gut inflammation alongside healing issues You have autoimmune-related inflammation You want the core healing and collagen benefits without KPV Histamine or mast cell issues are a concern Budget is a consideration (GLOW is less expensive) You want maximum comprehensive support Anti-inflammatory support is not a primary in one vial need

KLOW vs. Wolverine Stack

Choose KLOW If: Choose Wolverine Stack If: You want the complete package (healing + Your main goal is pure injury recovery inflammation + gut + anti-aging) You have complex recovery needs with Budget is a primary concern inflammatory components Gut health or systemic inflammation are You do not need anti-inflammatory or anti- priorities aging support Budget allows for the premium option You want a simpler, more affordable protocol

Success Tips

The Blue Color Is Normal

Reconstituted KLOW Blend will have a distinctive blue tint from the GHK-Cu component. This is completely normal and indicates that the copper is properly bound to the GHK peptide. If your solution is not blue, the product may be compromised and should not be used.

KPV Makes This Blend Gut-Friendly

If you have gut issues such as IBD, leaky gut, or food sensitivities, the KPV component specifically targets intestinal inflammation and barrier integrity through PepT1-mediated uptake into gut epithelial cells. Combined with BPC-157’s gut-healing properties, KLOW provides the most comprehensive gut support of any available peptide blend.

Reduced Injection Site Reactions

One notable benefit of the KLOW Blend is that both BPC-157 and KPV help moderate injection site reactions from GHK-Cu. KPV stabilizes mast cells and reduces histamine responses, while BPC-157 has general tissue-protective effects. Users often find KLOW more tolerable than standalone GHK-Cu injections.

Expect Gradual Results

The KLOW Blend works through multiple mechanisms with different timelines. Anti- inflammatory effects from KPV typically become noticeable within 1 to 2 weeks. Injury healing improvements appear within 2 to 4 weeks. Gut healing may take 2 to 6 weeks. Significant skin and collagen improvements generally require 8 to 12 weeks of consistent use.

Combine with Good Fundamentals

Peptides enhance your body’s healing capacity, but they work best alongside supportive lifestyle factors:

support KPV’s anti-inflammatory effects.

synthesis.

the blend’s anti-inflammatory benefits.

Storage and Handling

Before Reconstitution:

After Reconstitution:

appear, discard the vial.

Legal Status

United States: BPC-157 and TB-500 are not FDA-approved for human use and were classified as Category 2 bulk drug substances in 2023. KPV and GHK-Cu face similar restrictions for injectable use, though GHK-Cu is widely used in cosmetic products (marketed as Copper Tripeptide-1). The KLOW Blend is available as a research chemical.

WADA Status: BPC-157 and TB-500 are prohibited by the World Anti-Doping Agency under the S0 Unapproved Substances category. Athletes subject to drug testing should not use this combination.

Product Source

The KLOW Blend (GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg) is available for research purposes. When sourcing research-grade peptide blends, ensure the supplier provides third-party testing, certificates of analysis (COA), and proper documentation of purity (typically ≥99%). Always verify the legitimacy and quality standards of any peptide supplier.

Frequently Asked Questions

What makes KLOW different from GLOW? KLOW adds KPV (10 mg), a potent anti-inflammatory tripeptide derived from α-MSH. While GLOW provides healing plus anti-aging, KLOW adds serious inflammation control and gut- healing capability. Choose KLOW if gut health, IBD, or systemic inflammation are concerns. What is the blue color in the solution? The blue color comes from the GHK-Cu (copper peptide) component and is completely normal. It indicates that the copper is properly bound to the peptide. If your reconstituted solution is not blue, the product may be compromised. Will KLOW help with gut issues like IBD or leaky gut? Yes. The combination of KPV (which specifically targets gut inflammation and barrier integrity via PepT1-mediated uptake) and BPC-157 (which supports gut mucosal healing) makes KLOW the most comprehensive option for gut-related concerns among available peptide blends. Is KPV anti-inflammatory like NSAIDs or steroids? KPV provides potent anti-inflammatory effects but works through a fundamentally different mechanism than NSAIDs or corticosteroids. It inhibits NF-κB activation and reduces pro- inflammatory cytokines without the side effects associated with these drugs. It does not suppress the immune system like steroids, does not cause gastrointestinal damage like NSAIDs, and does not carry the same risk of long-term adverse effects. Does KPV affect skin pigmentation? No. Although KPV is derived from alpha-melanocyte-stimulating hormone (α-MSH), the KPV fragment does not stimulate melanocyte receptors involved in pigmentation. It retains the anti- inflammatory properties of the parent hormone without affecting skin color. How long should I run KLOW? For gut inflammation, 6 to 8 weeks is the standard protocol. For comprehensive healing, 4 to 8 weeks is recommended. For anti-aging plus maintenance, 8 to 16 weeks is typical. Take 4 to 6 weeks off between cycles. Is the KLOW Blend safe for long-term use? No long-term safety data exists for this specific combination. Most practitioners recommend cycling (4–16 weeks on, 4–6 weeks off) rather than continuous indefinite use. Consult a qualified healthcare provider to determine the appropriate protocol for your individual circumstances.

References

1. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166–178. 2. Kannengiesser K, Maaser C, Heidemann J, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(3):324–331. https://pubmed.ncbi.nlm.nih.gov/18092346/ 3. Luger TA, Brzoska T. α-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis. 2007;66(Suppl 3):iii52–iii55. 4. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153–159. https://pubmed.ncbi.nlm.nih.gov/30915550/ 5. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364–368. https://pubmed.ncbi.nlm.nih.gov/10469335/ 6. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.

Property Support

Our Property Support services are designed to help homeowners, property managers, and businesses maintain safe, clean, and well-functioning properties year-round.

Get In Touch